Tibor Keler is EXECUTIVE VP & CSO of Celldex Therapeutics, Inc.. Currently has a direct ownership of 7,357 shares of CLDX, which is worth approximately $191,723. The most recent transaction as insider was on Dec 07, 2022, when has been sold 16,860 shares (Common Stock, par value $0.001 per share) at a price of $36.93 per share, resulting in proceeds of $622,639. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.36K
0% 3M change
0% 12M change
Total Value Held $191,723

TIBOR KELER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2022
SELL
Open market or private sale
$622,639 $36.93 p/Share
16,860 Reduced 69.62%
7,357 Common Stock, par valu...
Dec 07 2022
BUY
Exercise of conversion of derivative security
$46,870 $2.78 p/Share
16,860 Added 41.04%
24,217 Common Stock, par valu...
TK

Tibor Keler

EXECUTIVE VP & CSO
Hampton, NJ

Track Institutional and Insider Activities on CLDX

Follow Celldex Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLDX shares.

Notify only if

Insider Trading

Get notified when an Celldex Therapeutics, Inc. insider buys or sells CLDX shares.

Notify only if

News

Receive news related to Celldex Therapeutics, Inc.

Track Activities on CLDX